Cutaneous side effects of oral corticosteroid therapy
Keywords:
Oral steroids, infections, atrophy, moon face, buffalo humpAbstract
Background Corticosteroids revolutionized the treatment of many skin disorders during 5thand 6th decades of last century. They have anti inflammatory, vasoconstrictor,antiproliferative and immunosuppressive effects.Objective The study was aimed to determine the frequency of cutaneous changes in patientson oral steroids and to see the pattern of these changes in our population.Material and methods The study was carried out in the department of dermatology, CivilHospital, Karachi. 204 patients fulfilling the inclusion criteria completed in the study. All thepatients were taking 60-80mg of oral steroids for a minimum of 2 weeks. Findings wererecorded on a preformed pro forma. Any relevant investigations were also carried out.Results were then compiled and tabulated.Results Multiple cutaneous infections was the most common side effect seen in 45 patients(22%, p>0.10). Moon face was seen in 39 patients (19%, p<0.001) and buffalo hump in 17patients (8.3%, p>0.08). Atrophic changes were a feature in 45 patients (22.5%, p>0.47).Other findings seen in our patients were acneiform eruptions in 18 patients (8.7%, p<0.001)and hypertrichosis in 8 patients (4%, p>0.013).Conclusion Oral steroid therapy is associated with significant cutaneous side effects whichdepend on the dose and duration of therapy. Bacterial infections remain the most commonside effect.References
Chosidow O, Lebrun-Vignes B,
Bourgault-Villada I. Local
corticosteroid therapy in dermatology.
Press Medic 2000; 28: 2050-6.
Seale JP, Compton MR. Side effects of
corticosteroid agents. Med J Aust 1986;
: 139-42.
Stuck AE, Minder CE, Frey FJ. Risk of
infectious complications in patients
taking glucocorticoids. Reviews Infect
Dis 1989; 11: 954-63.
Akhter SJ, Manzoor-ul-Hasan.
Treatment of pemphigus, a local
experience. J Pak Med Assoc 1989; 48:
-4.
Twycross R. The risks and benefits of
corticosteroids in advanced cancer.
Drug Safety 1994; 11: 163-78.
Sun-YN, Mckay LI, Dubois DC et al.
Pharmacokinetic/ pharmacodynamic
models for corticosteroid receptor
down regulation and glutamine
synthetase induction in rat skeletal
muscle by a receptor/ gene mediated
mechanism. J Pharmacol Exp Ther
; 28: 720-8.
Schwartz E, Mezick JA, Gendimenico
GJ, Kligman LH. In vivo prevention of
corticosteroid-induced skin atrophy by
tretinoin in the hairless mouse is
accompanied by modulation of
collagen, glucoseaminoglycans and
fibronectin. J Invest Dermatol 1994;
: 241-6.
Mc Micheal AJ, Griffiths CE, Talwar
HS et al. Concurrent application of
tretinoin (retinoic acid) partially
protects against corticosteroid induced
epidermal atrophy. Br J Dermatol
; 135: 164.
Lubach D, Hinze E. Development and
regression of dermal corticosteroid
atrophy change in skin fold and
thickness. Occup Environ Dermatoses
; 34: 146-9.
Soerma S, Lassus A, Salde L.
Assessment of atrophy of human skin
caused by corticosteroids using
chamber occlusion blister techniques.
Acta Derm Venereol 1984; 64: 41-5.
Zheng PS, Lavker RM, Lehman P,
Kligman AM. Morphologic
investigation in the rebound
phenomenon after corticosteroid
induced atrophy in human skin. J
Invest Dermatol 1984; 82: 345-52.
Evans NA. Gym and toxic: A profile of
male steroid users. Br J Sports
Med 1997; 31: 54-8.
Precious DS, Hoffman CD, Milter R.
Steroid acne after orthognathic surgery.
Oral Surg Oral Med Oral Path 1992;
: 279-81.
Samma S, Yoshikawa M, Futami T et
al. Corticosteroid as an antiemetic
agent in cancer chemotherapy with cis
diammine dichloroplatinum. J Cancer
Chemo 1985; 12: 561-5.
